Astellas Pharma Inc (ALPMY)
9.97
+0.27
(+2.78%)
USD |
OTCM |
May 02, 16:00
Astellas Pharma Market Cap: 17.88B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 02, 2024 | 17.88B |
May 01, 2024 | 17.39B |
April 30, 2024 | 17.12B |
April 29, 2024 | 17.27B |
April 26, 2024 | 17.12B |
April 25, 2024 | 17.11B |
April 24, 2024 | 16.98B |
April 23, 2024 | 17.02B |
April 22, 2024 | 17.09B |
April 19, 2024 | 17.03B |
April 18, 2024 | 16.98B |
April 17, 2024 | 16.96B |
April 16, 2024 | 16.75B |
April 15, 2024 | 16.62B |
April 12, 2024 | 17.12B |
April 11, 2024 | 18.45B |
April 10, 2024 | 18.35B |
April 09, 2024 | 18.77B |
April 08, 2024 | 18.86B |
April 05, 2024 | 19.01B |
April 04, 2024 | 18.97B |
April 03, 2024 | 19.17B |
April 02, 2024 | 19.35B |
April 01, 2024 | 19.31B |
March 28, 2024 | 19.27B |
Date | Value |
---|---|
March 27, 2024 | 19.62B |
March 26, 2024 | 19.83B |
March 25, 2024 | 19.54B |
March 22, 2024 | 19.76B |
March 21, 2024 | 19.85B |
March 20, 2024 | 19.63B |
March 19, 2024 | 19.51B |
March 18, 2024 | 19.45B |
March 15, 2024 | 19.41B |
March 14, 2024 | 19.13B |
March 13, 2024 | 19.17B |
March 12, 2024 | 19.29B |
March 11, 2024 | 19.53B |
March 08, 2024 | 19.04B |
March 07, 2024 | 19.27B |
March 06, 2024 | 19.38B |
March 05, 2024 | 19.36B |
March 04, 2024 | 19.87B |
March 01, 2024 | 19.99B |
February 29, 2024 | 19.60B |
February 28, 2024 | 19.69B |
February 27, 2024 | 19.70B |
February 26, 2024 | 19.78B |
February 23, 2024 | 19.70B |
February 22, 2024 | 19.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.62B
Minimum
Apr 15 2024
34.22B
Maximum
Jun 01 2020
27.75B
Average
28.14B
Median
Apr 15 2021
Market Cap Benchmarks
Takeda Pharmaceutical Co Ltd | 41.64B |
Nxera Pharma Co Ltd | 832.20M |
PeptiDream Inc | 1.699B |
Stemcell Holdings Inc | 1.643M |
Healios KK | 89.49M |
Market Cap Related Metrics
PS Ratio | 1.640 |
Price to Book Value | 1.677 |
Price to Free Cash Flow | 18.92 |
Price | 9.97 |
Earnings Yield | -0.08% |
Operating PE Ratio | 259.73 |